Back to today’s briefing

Story perspectives

Ro's $7B Valuation Sparks Pre-IPO Buzz in Telehealth

7/2/2025

50 10

Summary

Story summary

Ro, a pioneering digital telehealth company from New York City, is revolutionizing online prescriptions for sexual health, weight loss, and fertility. Since its inception in 2017, Ro has soared to a remarkable $7 billion valuation in 2022. Although an IPO isn't on the immediate horizon, the CEO hints that it could be in the cards, offering investors intriguing pre-IPO opportunities.

1 of 1

Story summary

Ro, a pioneering digital telehealth company from New York City, is revolutionizing online prescriptions for sexual health, weight loss, and fertility. Since its inception in 2017, Ro has soared to a remarkable $7 billion valuation in 2022. Although an IPO isn't on the immediate horizon, the CEO hints that it could be in the cards, offering investors intriguing pre-IPO opportunities.